Decentralised & hybrid clinical solutions

In line with the industry trend toward patient centricity that we have seen over the last few years, the pandemic outbreak has accelerated the interest and willingness of sponsors to adopt alternative methods to make clinical trials more resilient whatever the environmental conditions.

Experience and expertise to guide you through the process

Decentralised and hybrid trials bring a wide range of benefits to the patient and the sponsor. However, every study needs to be assessed for suitability and requires a framework based on a range of different aspects and considerations.  You need a partner who can guide you through the choices and support you in developing a solution that works specifically for your study. 

ICON is already deploying decentralised and hybrid clinical trials on a global basis in multiple therapeutic areas and will support you in navigating the assessment, planning and execution.